← Back to Search

Cognitive Behavioural Therapy (CBT) for Concussion

N/A
Waitlist Available
Led By Noah Silverberg, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-59 years old
Age 18-65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights

Study Summary

This trial will study a new therapy to improve memory problems after a concussion. Participants will receive either the therapy or another intervention. The trial will measure how well the therapy works.

Who is the study for?
This trial is for adults aged 18-65 who had a concussion 6-24 months ago, meet criteria for Functional Cognitive Disorder, speak English fluently, and have regular internet access. It's not for those with serious conditions like cancer or MS, MRI contraindications, failed validity tests, severe mental illness requiring recent hospitalization, substance abuse disorders, or on memory-impairing meds.Check my eligibility
What is being tested?
The study is testing a new cognitive behavioural therapy (CBT) aimed at improving memory after a concussion. Participants will be randomly assigned to either this CBT or an alternative cognitive rehabilitation program to compare effectiveness. The focus is on how feasible the treatment is based on recruitment success and participant adherence.See study design
What are the potential side effects?
Since the interventions are non-medical therapies (CBT and cognitive rehabilitation), they typically do not have side effects like drugs do. However, participants may experience emotional discomfort discussing their experiences during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 59 years old.
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Memory concern
Patient adherence
Recruitment
+3 more
Secondary outcome measures
Avoidance
Catastrophization
Patient Global Impression of Change
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive Behavioural Therapy (CBT)Experimental Treatment1 Intervention
11 weekly sessions of cognitive behavioural therapy (CBT) delivered over videoconference
Group II: Cognitive RehabilitationActive Control1 Intervention
11 weekly sessions of traditional cognitive rehabilitation delivered over videoconference
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Behavioural Therapy (CBT)
2017
N/A
~780

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,466,931 Total Patients Enrolled
Harvard Medical School (HMS and HSDM)OTHER
195 Previous Clinical Trials
1,316,015 Total Patients Enrolled
Noah Silverberg, PhDPrincipal InvestigatorUniversity of British Columbia
5 Previous Clinical Trials
474 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the goals of this research endeavor?

"This trial, to be assessed in a Week 0 period, aims at Retention as its primary goal. Secondary objectives include Avoidance (as indicated by Fear-Avoidance of Memory Loss Scale scores ranging from 5 to 25; higher numbers signify greater fear), Reliance on others (Relative subscale of the Memory Compensation Questionnaire with values between 0 and 115; high scores indicate higher reliance), and Patient Global Impression of Change (Single item rated from 1 [much worse] to 5 [much better] since treatment began)."

Answered by AI

Are there any participants currently being sought for the experiment?

"Affirmative. Clinicaltrials.gov verifies that since its initial posting on November 29th 2022, this medical trial is still actively recruiting participants from 10 locations with a goal of 30 patients."

Answered by AI

Is the participant criterion for this research trial inclusive of individuals over 45 years old?

"This clinical trial has an age requirement of 18 to 65 for potential enrollees. In contrast, there are 100 studies available for people under the legal age and 347 trials open to those aged over 65."

Answered by AI

What is the total enrollment of participants in this trial?

"Correct. According to clinicaltrials.gov, this medical study is actively recruiting patients and was originally posted on November 29th 2022. 30 individuals must be enrolled from 10 locations in total."

Answered by AI

What sites are hosting this exploration into potential treatments?

"This clinical trial has 10 sites, including Lion's Gate Hospital in Richmond, Richmond Hosptial in Vancouver and Vancouver General Hospital in Surrey. Additionally, there are 7 other locations that are participating."

Answered by AI

Who meets the eligibility criteria for participation in this trial?

"Eligibility criteria for this research study necessitate that participants have a neurological disorder and be of age between 18 to 65. As such, 30 candidates must be enrolled in total."

Answered by AI

Who else is applying?

What state do they live in?
Florida
Alabama
How old are they?
18 - 65
What site did they apply to?
Lifemark (Post-Concussion Management Program)
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0
~13 spots leftby Apr 2025